SCHEMBL3755557

SCHEMBL3755557

c1cc(OCC2CO2)c(OCC2CO2)cc1C12CC3CC(c4ccc(OCC5CO5)c(OCC5CO5)c4)(C1)CC(c1ccc(OCC4CO4)c(OCC4CO4)c1)(C3)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
GLA P06280 1/20 0.42
TP53 P04637 3/20 0.41
TSHR P16473 3/20 0.41
HIF1A Q16665 2/20 0.41
CYP3A4 P08684 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 2/20 0.37
CYP1A2 P05177 1/20 0.37
PPARG P37231 1/20 0.37
PKM P14618 2/20 0.34
GAA P10253 2/20 0.34
LMNA P02545 1/20 0.34
VDR P11473 1/20 0.33
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2425547 0.92 ALDH1A1 (0.40) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL3759915 0.91 ALDH1A1 (0.46) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL2420659 0.89 KMT2A (0.43) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL2008109 0.81 ALDH1A1 (0.48) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL3764532 0.79 ALDH1A1 (0.41) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL3766035 0.78 ALDH1A1 (0.49) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL549618 0.78 KMT2A (0.41) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL549765 0.78 KMT2A (0.41) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL3758414 0.78 ALDH1A1 (0.53) ALDH1A1GLATP53TSHRHIF1A
SCHEMBL2422578 0.77 ALDH1A1 (0.42) ALDH1A1GLATP53TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084650-B2 Adamantane derivative, resin composition containing same, and optoelectronic member and sealing agent for electronic circuit using those IDEMITSU KOSAN CO., LTD. (JP) 2011-12-27 US disclosed
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE IDEMITSU KOSAN CO., LTD. (JP) 2010-11-25 US disclosed
EP-1985616-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE Idemitsu Kosan Co., Ltd. (JP) 2008-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298491-A1 ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC MEMBER AND SEALING AGENT FOR ELECTRONIC CIRCUIT USING THOSE AOC1, ASIC1, ICAM1 ALDH1A1 10/4885GLA 2037/4885TP53 4522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.